Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | APAF1 | O14727 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL16668993 | 0.95 | FDPS (0.36) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| Sulfuric Acid SCHEMBL30712585 | 0.89 | FDPS (0.39) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| SCHEMBL4281206 | 0.88 | FDPS (0.38) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| Sulfuric Acid SCHEMBL1101232 | 0.86 | FDPS (0.40) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| SCHEMBL2691328 | 0.86 | FDPS (0.33) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| Trifluoromethanesulfonic Acid SCHEMBL2028441 | 0.84 | FDPS (0.36) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| SCHEMBL9934092 | 0.84 | FDPS (0.38) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| SCHEMBL14635383 | 0.84 | FDPS (0.35) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| Sulfuric Acid SCHEMBL28517102 | 0.83 | FDPS (0.39) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| Trifluoromethanesulfonic Acid SCHEMBL16108388 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119833706-A | Three-dimensional solid lithium battery and preparation method thereof | 东莞市威力源电子科技有限公司 | 2025-04-15 | — | — | CN | claimed |
| US-20080015362-A1 | Process for the preparation of optically active (S)-(+)-N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine | TEVA PHARMACEUTICALS USA, INC. | 2008-01-17 | — | — | US | claimed |
| US-20070238883-A1 | Process for the preparation of(s)-(+)-N,N-dimethyl-3-(1-Naphthalenyloxy)-3-(2-Thienyl)propanamine, A duloxetine intermediate | TEVA PHARMACEUTICALS USA, INC. | 2007-10-11 | — | — | US | claimed |
| CN-119833706-A | Three-dimensional solid lithium battery and preparation method thereof | 东莞市威力源电子科技有限公司 | 2025-04-15 | — | — | CN | disclosed |
| CN-116685468-A | Surface protective film | 日东电工株式会社 | 2023-09-01 | — | — | CN | disclosed |
| EP-3774762-B1 | PROCESS FOR PRODUCING A CYCLIC ACETAL IN A HETEROGENEOUS REACTION SYSTEM | CELANESE SALES GERMANY GMBH (DE) | 2023-08-30 | — | — | EP | disclosed |
| CN-116670242-A | Surface protective film | 日东电工株式会社 | 2023-08-29 | — | — | CN | disclosed |
| CN-116635228-A | Surface protective film | 日东电工株式会社 | 2023-08-22 | — | — | CN | disclosed |
| CN-116438273-A | Film with adhesive layer | 日东电工株式会社 | 2023-07-14 | — | — | CN | disclosed |
| EP-3774762-A1 | PROCESS FOR PRODUCING A CYCLIC ACETAL IN A HETEROGENEOUS REACTION SYSTEM | Celanese Sales Germany GmbH (DE) | 2021-02-17 | — | — | EP | disclosed |
| CN-111971276-A | Method for producing cyclic acetals in heterogeneous reaction systems | 塞拉尼斯销售德国有限公司 | 2020-11-20 | — | — | CN | disclosed |
| US-9499512-B2 | Process for producing a cyclic acetal in a heterogeneous reaction system | TICONA GMBH (DE) | 2016-11-22 | — | — | US | disclosed |
| US-20140350216-A1 | Process for Producing A Cyclic Acetal In A Heterogeneous Reaction System | NUTRINOVA NUTRITION SPECIALTIES & FOOD INGREDIENTS GMBH (DE) | 2014-11-27 | — | — | US | disclosed |
| EP-2782908-A1 | PROCESS FOR PRODUCING A CYCLIC ACETAL IN A HETEROGENEOUS REACTION SYSTEM | Ticona GmbH (DE) | 2014-10-01 | — | — | EP | disclosed |
| US-20140182484-A1 | Process For Producing Polyoxymethylene Polymers With Long-Chain Alkyl End Groups, and Polymers Made Therefrom | TICONA GMBH (DE) | 2014-07-03 | — | — | US | disclosed |
| US-20140182485-A1 | Polyoxymethylene Polymer With Long Chain Alkylene Glycol End Groups | TICONA GMBH (DE) | 2014-07-03 | — | — | US | disclosed |
| WO-2013076290-A1 | PROCESS FOR PRODUCING A CYCLIC ACETAL IN A HETEROGENEOUS REACTION SYSTEM | TICONA GMBH (DE) | 2013-05-30 | — | — | WO | disclosed |
| US-20120126931-A1 | ELECTROLYTE COMPOSITION | SERICOL LIMITED (GB) | 2012-05-24 | — | — | US | disclosed |
| US-20080015362-A1 | Process for the preparation of optically active (S)-(+)-N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine | TEVA PHARMACEUTICALS USA, INC. | 2008-01-17 | — | — | US | disclosed |
| US-20070238883-A1 | Process for the preparation of(s)-(+)-N,N-dimethyl-3-(1-Naphthalenyloxy)-3-(2-Thienyl)propanamine, A duloxetine intermediate | TEVA PHARMACEUTICALS USA, INC. | 2007-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080015362-A1 | Process for the preparation of optically active (S)-(+)-N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine | HTR3A, PNMT, TPH1 | FDPS 1003/4885SMN1; SMN2 302/4885MEN1 3527/4885 |
| US-20140350216-A1 | Process for Producing A Cyclic Acetal In A Heterogeneous Reaction System | ATIC, DCXR, ALDOA | FDPS 137/4885SMN1; SMN2 3068/4885MEN1 4213/4885 |
| US-20070238883-A1 | Process for the preparation of(s)-(+)-N,N-dimethyl-3-(1-Naphthalenyloxy)-3-(2-Thienyl)propanamine, A duloxetine intermediate | DNTT, NES, PNMT | FDPS 1593/4885SMN1; SMN2 198/4885MEN1 3014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.